RCKT

Conviction 28HealthcareScan · Thu, Sep 24, 2026

Rocket Pharmaceuticals, Inc. (RCKT) closed at $2.70 (-10.76%) on Sep 24, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 28, RS Rating 25, -49.1% from its 52-week high, -22.1% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

RCKT$2.70-10.76%

ResistanceSupportVol 14Insider sell

Vol MA14 1.82M

Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24

ROCKET PHARMACEUTICALS, INC.PHARMACEUTICAL PREPARATIONSwww.rocketpharma.com ↗

Price2.70

Change-10.76%

Gap+0.17%

Rel volume2.38×

Avg volume1.75M

Avg $ vol5.99M

SMA 203.51

SMA 503.45

SMA 2003.59

Price vs 50-21.95%

Price vs 200-24.96%

MA stackbearish

50/200 cross—

Supertrenddown · 3.57

RSI (14)28

MACD hist-0.09

MACD cross—

Stoch %K / %D2 / 9

ADX (14)17

+DI / −DI17 / 34

RSI divergence—

MACD divergence—

ATR %8.71%

ADR %6.66%

52w high5.30

52w low2.60

From 52w high-49.15%

Above 52w low+3.65%

New 52w highNo

SqueezeOff

Bollinger width32.82%

%B-0.21

Donchian pos2.26%

Donchian high3.99

Donchian low2.67

AVWAP (52w high)3.63

vs AVWAP high-25.83%

AVWAP (52w low)3.41

vs AVWAP low-20.88%

OBV trendDown

Chaikin MF (20)-0.28

Today vs 20d2.38×

Avg vol (14d)1.82M

Avg vol (20d)1.75M

Avg $ vol (20d)5.99M

Market cap295.84M

RS Rating25 / 99

RS 3m (vs SPY)-21.31%

RS 6m (vs SPY)-59.23%

RS line new highNo

Trend template2/8

Technical rank8.8

1 week-23.00%

1 month-28.70%

3 months-16.82%

6 months-42.41%

1 year-13.06%

YTD-22.11%

P/E-1.33

P/B0.80

P/S—

P/FCF-1.55

EPS-2.01

Div yield—

ROE-60.49%

ROA-52.74%

Debt/Eq—

Current9.24

EV/EBITDA-0.32

Gross margin—

Net margin—

Rev growth—

EPS growth13.77%

Price target10.88

Target upside303.71%

Analyst ratingBuy

Institutional100.44%

Ent. value71.34M

Revenue0

Net income123.21M

Gross profit—

Free cash flow-190.45M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out109.19M

Employees202

ListedWed, Feb 18, 2015

Free float84.02M

Float %77.0%

Short interest14.71M

Days to cover9.8d

Short volume57.6%

Squeeze score87 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.15 vs $0.28

Last surprise-153.6% miss

Setup gradeD

Conviction28 / 100

Pattern quality—

Tech rank8.8 / 100

Group rank59 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance3.97

Support3.12

Days since event—

Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in RCKT

All disclosures →

No recent disclosed trades by Congress in RCKT. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in RCKT · open-market 6 sells

Insider	Side	Shares	Value	Traded	Filed
Wilson Martin General Counsel · Common Stock · 2026-09-11	Sell	75.36K	$256K	2026-09-11	2026-09-15
Shah Gaurav CEO · Common Stock · 2026-08-18	Sell	2.29K	$8K	2026-08-18	2026-08-20
Wilson Martin General Counsel · Common Stock · 2026-08-18	Sell	631	$2K	2026-08-18	2026-08-20
Wilson Martin General Counsel · Common Stock · 2026-08-13	Sell	3.49K	$12K	2026-08-13	2026-08-17
Shah Gaurav CEO · Common Stock · 2026-08-13	Sell	2.84K	$10K	2026-08-13	2026-08-17
Chaudhuri Sarbani See Remarks · Common Stock · 2026-08-11	Sell	4.7K	$16K	2026-08-11	2026-08-13
Militello John See Remarks · Stock Option (Right to Buy) · 2026-05-26	Disposition	24.55K	—	2026-05-26	2026-05-28
Militello John See Remarks · Stock Option (Right to Buy) · 2026-05-26	Grant	16.06K	—	2026-05-26	2026-05-28
Militello John See Remarks · Stock Option (Right to Buy) · 2026-05-26	Disposition	2K	—	2026-05-26	2026-05-28
Militello John See Remarks · Stock Option (Right to Buy) · 2026-05-26	Disposition	18K	—	2026-05-26	2026-05-28

SEC filings

EDGAR filings in RCKT · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.